Medical/Pharmaceuticals

CSafe Bolsters Its Digital Ecosystem Launching TracSafe Data Loggers and CSafe Connect Portal

TracSafe fit-for-purpose data loggers link directly to the comprehensive CSafe Connect customer portal creating the next iteration of a progressive customer-focused digital ecosystem MONROE, Ohio, Jan. 10, 2023 /PRNewswire/ -- CSafe, the largest provider of a complete range of active and passive ...

2023-01-10 20:00 3300

Sarah Otten Joins Medison Pharma as VP, GM Americas Region

Sarah Otten will lead Medison's Americas region covering Canada and Latin America. Sarah brings vast geographical expansion experience in international markets. PETACH TIKVAH, Israel and ZUG, Switzerland, Jan. 9, 2023 /PRNewswire/ -- Medison Pharma ("Medison"), a...

2023-01-10 19:54 2167

Clarivate Identifies Fifteen Potential Blockbuster Drugs in Annual Drugs to Watch Report

Report highlights personalized medicines ensuring greater efficacy for rare diseases and previously untreatable conditions Promising therapeutic developments for HIV, Parkinson's disease, Crohn's disease, alopecia, multiple myeloma and breast cancer on horizon LONDON, Jan. 10, 2023 /PRNewswire/ ...

2023-01-10 16:00 1899

Appointment of Dr. David John Jeans CBE as HistoIndex's Non-Executive Chairman

SINGAPORE, Jan. 10, 2023 /PRNewswire/ -- The Board of Directors (the "Board") of HistoIndex (the "Company") would like to announce the following changes in appointments to the Board with effect from6th December 2022: (1) Mr Sim Giok Lak's decision to step down as Non-Executive Chairman of the Bo...

2023-01-10 13:01 1850

Bangkok Dusit Medical Services extends partnership with CNN to explore global health issues

HONG KONG, Jan. 10, 2023 /PRNewswire/ -- Bangkok Dusit Medical Services Public Company Limited (BDMS), the largest healthcare network inThailand, reinforces its long-standing partnership with CNN International Commercial (CNNIC) with the sponsorship of 'Vital Signs

2023-01-10 11:24 2455

Lydus Medical Announces FDA Clearance of Vesseal™, The Microvascular Anastomosis Aid Device for Small Arteries

RA'ANANA, Israel, Jan. 10, 2023 /PRNewswire/ -- Lydus Medical is pleased to announce that the Vesseal™ has received FDA clearance 510(k). The Vesseal™ is a microvascular anastomosis suture deployment system, for standardized omni-vessel anastomoses, enabling simp...

2023-01-10 09:00 1990

Insilico Medicine Announces Positive Topline Results of the New Zealand Phase I Trial of INS018_055, an AI-Designed Drug for an AI-Discovered Target

NEW YORK and HONG KONG, Jan. 10, 2023 /PRNewswire/ -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug R&D company, today announces positive topline results of safety, tolerability, and pharmacokinetics (PK) from thePhase I clinical trial of INS018_055

2023-01-10 05:00 3995

The Latest Global Survey from ISAPS Reports a Significant Rise in Aesthetic Surgery Worldwide

Total surgical and non-surgical procedures increased by 19.3% MOUNT ROYAL, N.J., Jan. 10, 2023 /PRNewswire/ -- The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual Global Survey on Aesthetic/Cosmetic Procedures today, showing a 19.3% overall increase ...

2023-01-10 00:16 2932

Innovent Announces First Participant Dosed in a Phase 3 Clinical Study (DREAMS-1) of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes

ROCKVILLE, Md. and SUZHOU, China, Jan. 10, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...

2023-01-10 00:00 3257

Shanton Screens First Subjects in Phase 2b Refractory/Tophaceous Gout Study with SAP-001

SAP-001 is an oral once-a-day investigational gout product with Best-in-Class potential for acute and chronic use in uncontrolled patients BRIDGEWATER, N.J., Jan. 9, 2023 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a groundbreaking treatment for refractory and top...

2023-01-09 22:00 2407

Gift of Life Donor Program: Nation's Leader for 15 Years

Gift of Life Staff, Community & Hospital Partners Continue Proud History of Saving Lives Together PHILADELPHIA, Jan. 9, 2023 /PRNewswire/ -- Gift of Life Donor Program continues to lead the U.S. in life-saving organ donations for a milestone 15 consecutive years thanks to its dedicated staff, ho...

2023-01-09 22:00 2842

Mars Petcare and the Broad Institute create open-access database of dog and cat genomes to advance preventive pet care

* The genome database will power ongoing scientific efforts worldwide and help advance individualized pet health care * Insights from this partnership will feed into the MARS PETCARE BIOBANK™, a longitudinal study to understand pet health and disease, transforming pet care for future generati...

2023-01-09 21:15 2398

SoniVie Raises $60m in Round C Financing, and Appoints New Board Members

The funds, provided by new investors and current shareholder, will be used to support the Company clinical and regulatory path towards pre-market approval of its TIVUS™ technology for the treatment of hypertension TEL AVIV, Israel, Jan. 9, 2023 /PRNewswire/ -- SoniVie Ltd.

2023-01-09 20:00 2732

Luye Pharma's Innovative Anti-Cancer Therapy Lurbinectedin to Benefit "Named Patients" in Hong Kong

HONG KONG, Jan. 9, 2023 /PRNewswire/ -- Luye Pharma Group today announced the launch of the Named Patient Program (NPP) inHong Kong, China, providing eligible local patients immediate access to the innovative anti-cancer therapy Lurbinectedin. Luye Pharma has signed an agreement with Abacus Medic...

2023-01-09 18:57 3502

Earable(R) Disrupts Sleep Tech with FRENZ(TM) Brainband Global Launch Event at CES 2023

LAS VEGAS, Jan. 7, 2023 /PRNewswire/ -- Earable® Neuroscience held a global launch event for its FRENZ™ Brainband at CES 2023. During the event, the company discussed innovations behind the award-winning device, potential to disrupt sleep tech, a special promotional price, and its 88 Pioneer proj...

2023-01-07 08:00 4291

Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering

SYDNEY, Jan. 6, 2023 /PRNewswire/ -- Parnell Pharmaceuticals Holdings Ltd (OTC Pink® Open Market: PARNF) ("Parnell") today announced the extension of the backstopped rights offering to raise gross proceeds of approximatelyUS$4.0 million (the "Rights Offering"). Under the terms of the Rights Offer...

2023-01-06 15:05 3981

CES 2023: OMRON Healthcare to Unveil New Efforts to Realize Vision of "Going for Zero" -- Zero Heart Attacks and Zero Strokes

- "Viso," New UK Remote Patient Monitoring Service, to Be Launching in Early 2023 - KYOTO, Japan, Jan. 6, 2023 /PRNewswire/ -- OMRON Healthcare Co., Ltd. (hereinafter the Company) is unveiling a new UK remote patient-monitoring service to realize its "Going for Zero" vision to eliminate heart at...

2023-01-06 14:00 2903

Innovent Announces the National Medical Products Administration in China Has Accepted and Granted Priority Review Designation to the New Drug Application for Parsaclisib (PI3Kδ inhibitor) for the Treatment of Relapsed or Refractory Follicular Lymphoma

ROCKVILLE, Md. and SUZHOU, China, Jan. 6, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...

2023-01-06 12:22 4009

Kira to Present at the 41st Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass. and SUZHOU, China, Jan. 5, 2023 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced that Frederick Beddingfield M.D., Ph.D., Chief Executive Officer, will present a...

2023-01-05 23:30 2664

AMR Action Fund Announces Investment in BioVersys AG

Deal marks Fund's first investment in Europe and advances its mission of enabling the launch of two to four antimicrobials by 2030 BOSTON, Jan. 5, 2023 /PRNewswire/ --  The AMR Action Fund, the world's largest public-private partnership investing in biotech companies that are developing antimicr...

2023-01-05 20:00 7732
1 ... 138139140141142143144 ... 398